company background image
RAD logo

Radiopharm Theranostics ASX:RAD Stock Report

Last Price

AU$0.035

Market Cap

AU$62.4m

7D

16.7%

1Y

-68.2%

Updated

18 Sep, 2024

Data

Company Financials +

Radiopharm Theranostics Limited

ASX:RAD Stock Report

Market Cap: AU$62.4m

RAD Stock Overview

Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.

RAD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Radiopharm Theranostics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Radiopharm Theranostics
Historical stock prices
Current Share PriceAU$0.035
52 Week HighAU$0.15
52 Week LowAU$0.027
Beta0.83
11 Month Change-5.41%
3 Month Change2.94%
1 Year Change-68.18%
33 Year Changen/a
5 Year Changen/a
Change since IPO-91.25%

Recent News & Updates

Recent updates

We're A Little Worried About Radiopharm Theranostics' (ASX:RAD) Cash Burn Rate

Jan 06
We're A Little Worried About Radiopharm Theranostics' (ASX:RAD) Cash Burn Rate

Here's Why Radiopharm Theranostics (ASX:RAD) Must Use Its Cash Wisely

Sep 02
Here's Why Radiopharm Theranostics (ASX:RAD) Must Use Its Cash Wisely

Shareholder Returns

RADAU BiotechsAU Market
7D16.7%-1.6%1.7%
1Y-68.2%14.0%12.4%

Return vs Industry: RAD underperformed the Australian Biotechs industry which returned 14% over the past year.

Return vs Market: RAD underperformed the Australian Market which returned 12.4% over the past year.

Price Volatility

Is RAD's price volatile compared to industry and market?
RAD volatility
RAD Average Weekly Movement11.7%
Biotechs Industry Average Movement11.6%
Market Average Movement8.5%
10% most volatile stocks in AU Market16.8%
10% least volatile stocks in AU Market3.5%

Stable Share Price: RAD's share price has been volatile over the past 3 months.

Volatility Over Time: RAD's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2021n/aRiccardo Canevariwww.radiopharmtheranostics.com

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It is developing its lead products comprising Nano-mAbs and AVB6 Integrin. The company was incorporated in 2021 and is based in Carlton, Australia.

Radiopharm Theranostics Limited Fundamentals Summary

How do Radiopharm Theranostics's earnings and revenue compare to its market cap?
RAD fundamental statistics
Market capAU$62.38m
Earnings (TTM)-AU$47.95m
Revenue (TTM)AU$1.64m

44.3x

P/S Ratio

-1.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RAD income statement (TTM)
RevenueAU$1.64m
Cost of RevenueAU$21.61m
Gross Profit-AU$19.97m
Other ExpensesAU$27.98m
Earnings-AU$47.95m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.023
Gross Margin-1,215.69%
Net Profit Margin-2,919.65%
Debt/Equity Ratio0%

How did RAD perform over the long term?

See historical performance and comparison